Assenagon Asset Management S.A. Invests $1.39 Million in Teleflex Incorporated $TFX

Key Points

• Assenagon Asset Management acquired 10,974 Teleflex shares worth approximately $1.39 million, while institutional investors collectively own 95.62% of the company.
• Teleflex exceeded quarterly earnings expectations, reporting EPS of $1.76 versus the $1.28 consensus and revenue of $570.33 million, up 28.9% year over year.
• Analysts maintain a consensus “Hold” rating with an average price target of $151.80, while Teleflex announced a quarterly dividend of $0.34 per share, representing a 1.0% yield.

Assenagon Asset Management S.A. acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 10,974 shares of the medical technology company's stock, valued at approximately $1,391,000.

Other institutional investors have also recently made changes to their positions in the company. AQR Capital Management LLC lifted its holdings in Teleflex by 478.1% during the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock valued at $287,603,000 after buying an additional 1,956,811 shares in the last quarter. Irenic Capital Management LP purchased a new position in shares of Teleflex in the first quarter worth $104,061,000. Norges Bank acquired a new stake in Teleflex during the 4th quarter worth about $66,076,000. Wolf Hill Capital Management LP purchased a new stake in Teleflex in the fourth quarter valued at approximately $47,405,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Teleflex by 123.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company's stock valued at $80,855,000 after acquiring an additional 365,663 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Price Performance

TFX stock opened at $136.98 on Friday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $145.00. The stock's 50 day moving average price is $132.38 and its 200 day moving average price is $123.67. The firm has a market cap of $5.80 billion, a P/E ratio of -5.88, a PEG ratio of 0.92 and a beta of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analysts' expectations of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The firm's quarterly revenue was up 28.9% compared to the same quarter last year. During the same quarter last year, the business posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex's dividend payout ratio (DPR) is presently -5.84%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Zacks Research raised shares of Teleflex from a "strong sell" rating to a "hold" rating in a report on Tuesday, April 28th. Raymond James Financial restated an "outperform" rating and issued a $150.00 target price on shares of Teleflex in a report on Friday, May 8th. Truist Financial lifted their price target on shares of Teleflex from $143.00 to $150.00 and gave the company a "hold" rating in a research report on Monday. BMO Capital Markets began coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an "outperform" rating and a $159.00 target price for the company. Finally, Wells Fargo & Company lifted their price objective on Teleflex from $130.00 to $138.00 and gave the company an "equal weight" rating in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $151.80.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source